- Home
- MRSN vs STHO Comparison
MRSN vs STHO Comparison
Compare MRSN & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRSN | STHO |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.8M | 112.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRSN | STHO |
|---|---|---|
| Price | $27.78 | $7.63 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $30.38 | N/A |
| AVG Volume (30 Days) | ★ 237.3K | 50.2K |
| Earning Date | 11-14-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $33,180,000.00 | ★ $117,547,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $6.06 |
| 52 Week High | $70.73 | $11.32 |
Technical Indicators
Market Signals| Indicator | MRSN | STHO |
|---|---|---|
| Relative Strength Index (RSI) | 83.68 | 48.76 |
| Support Level | $27.31 | $7.76 |
| Resistance Level | $28.36 | $8.01 |
| Average True Range (ATR) | 0.52 | 0.24 |
| MACD | -0.26 | 0.03 |
| Stochastic Oscillator | 51.65 | 45.56 |
Price Performance
Historical ComparisonAbout MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.